A Trial of Low-dose Adjunctive alTeplase During prIMary PCI
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 440 participants.
Also called NCT02257294
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 440 participants
- Sponsor
- Registry
-
NCT02257294
-
- Other papers using this trial's data
- Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial
- Effects of Intracoronary Alteplase on Microvascular Function in Acute Myocardial Infarction
- Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02257294. Randomized; triple masking; primary purpose treatment. Start 2016-03 (actual); primary completion 2018-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial of Low-dose Adjunctive alTeplase During prIMary PCI
- Acronym
- T-TIME
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Alteplase
- Intervention (Other)
- Placebo
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Collaborator
- University of Glasgow
- Collaborator
- National Institute for Health Research, United Kingdom
Record details
- Record id
cardio:ct-nct02257294- Content hash
ecf8d4583fff74c803aa1be3e0004228a45a98db372cead5d4bc5f0380203eeb